RGCRegencell Bioscience Holdings Limited Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic

Current Price: $30.83 (+0.10% today)

Market Cap: $15.23B

P/E (TTM): -4249.30

Relative Strength (RS%): 40

-63.1% from 52-week high

Back to Scanner

RGC

NASDAQRS 40Score 26

Regencell Bioscience Holdings Limited

HealthcareDrug Manufacturers - Specialty & Generic$15.23B
$30.83
+0.1% ($0.03)
-63.1% from 52W High
P/E (TTM)
-4249.30
Fwd P/E
PEG
Analyst Upside
EPS Growth
Gross Margin
0.0%
ROE
-61.9%
D/E
0.11
Div Yield
0.0%
Avg Volume
330.0K

Price Chart

Key Levels

SMA 200
$20.26
SMA 50
$27.09
Price
$30.83
52W High
$83.55

Setup Radar

0/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst